产品标题 产品货号 产品规格 厂家
Polymerase (DNA directed), delta 1, catalytic subunit 125kDa (POLD1) from ORIGENE TECHNOLOGIESLY400947100 ugORIGENE TECHNOLOGIES
Polymerase (DNA-directed), delta interacting protein 2 (POLDIP2) from ORIGENE TECHNOLOGIESLY402448100 ugORIGENE TECHNOLOGIES
Polymerase (DNA-directed), delta interacting protein 3 (POLDIP3), transcript variant 1 from ORIGENE TECHNOLOGIESLY410211100 ugORIGENE TECHNOLOGIES
Polymerase (DNA-directed), delta 4 (POLD4) from ORIGENE TECHNOLOGIESLY412048100 ugORIGENE TECHNOLOGIES
Polymerase (DNA directed), delta 2, regulatory subunit 50kDa (POLD2), transcript variant 1 from ORIGENE TECHNOLOGIESLY426719100 ugORIGENE TECHNOLOGIES
Polymerase (DNA directed), delta 2, regulatory subunit 50kDa (POLD2), transcript variant 2 from ORIGENE TECHNOLOGIESLY416786100 ugORIGENE TECHNOLOGIES
Human Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIESCS7170275x5umORIGENE TECHNOLOGIES
Human Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIESCS8009585x5umORIGENE TECHNOLOGIES
Human Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIESCS8014095x5umORIGENE TECHNOLOGIES
Human Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIESCS8027605x5umORIGENE TECHNOLOGIES
Human Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIESCS8028215x5umORIGENE TECHNOLOGIES
Human Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIESCS8053675x5umORIGENE TECHNOLOGIES
Human Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIESCS8056245x5umORIGENE TECHNOLOGIES
Human Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIESCS8065505x5umORIGENE TECHNOLOGIES
Human Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIESCS8075145x5umORIGENE TECHNOLOGIES
Human Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIESCS8129005x5umORIGENE TECHNOLOGIES
Human Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIESCS8149545x5umORIGENE TECHNOLOGIES
Human Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIESCS8150145x5umORIGENE TECHNOLOGIES
Human Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIESCS8150335x5umORIGENE TECHNOLOGIES
Human Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIESCS8150355x5umORIGENE TECHNOLOGIES
Human Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIESCS8150385x5umORIGENE TECHNOLOGIES
Human Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIESCS8150435x5umORIGENE TECHNOLOGIES
Human Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIESCS8150465x5umORIGENE TECHNOLOGIES
Human Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIESCS5000905x5umORIGENE TECHNOLOGIES
Human Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIESCS5002185x5umORIGENE TECHNOLOGIES
Human Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIESCS5008305x5umORIGENE TECHNOLOGIES
Human Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIESCS5010795x5umORIGENE TECHNOLOGIES
Human Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIESCS5015325x5umORIGENE TECHNOLOGIES
Human Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIESCS5019955x5umORIGENE TECHNOLOGIES
Human Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIESCS5022565x5umORIGENE TECHNOLOGIES
Human Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIESCS5024315x5umORIGENE TECHNOLOGIES
Human Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIESCS5109845x5umORIGENE TECHNOLOGIES
Human Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIESCS5137825x5umORIGENE TECHNOLOGIES
Human Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIESCS5214305x5umORIGENE TECHNOLOGIES
Human Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIESCS5215885x5umORIGENE TECHNOLOGIES
Human Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIESCS5237605x5umORIGENE TECHNOLOGIES
Human Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIESCS5285245x5umORIGENE TECHNOLOGIES
Human Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIESCS5351865x5umORIGENE TECHNOLOGIES
Human Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIESCS5412655x5umORIGENE TECHNOLOGIES
Human Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIESCS5431285x5umORIGENE TECHNOLOGIES
Human Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIESCS5442475x5umORIGENE TECHNOLOGIES
Human Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIESCS5459305x5umORIGENE TECHNOLOGIES
Human Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIESCS5516045x5umORIGENE TECHNOLOGIES
Human Skin; Malignant melanoma, metastatic from ORIGENE TECHNOLOGIESCS5589575x5umORIGENE TECHNOLOGIES
Human Colon; Colitis, ulcerative, chronic active from ORIGENE TECHNOLOGIESCS8078745x5umORIGENE TECHNOLOGIES
Human Colon; Colitis, ulcerative, chronic active from ORIGENE TECHNOLOGIESCS8081425x5umORIGENE TECHNOLOGIES
Human Colon; Colitis, ulcerative, chronic active from ORIGENE TECHNOLOGIESCS8081665x5umORIGENE TECHNOLOGIES
Human Colon; Colitis, ulcerative, chronic active from ORIGENE TECHNOLOGIESCS8087715x5umORIGENE TECHNOLOGIES
Human Colon; Colitis, ulcerative, chronic active from ORIGENE TECHNOLOGIESCS8087735x5umORIGENE TECHNOLOGIES
Human Colon; Colitis, ulcerative, chronic active from ORIGENE TECHNOLOGIESCS8088405x5umORIGENE TECHNOLOGIES
 |< < 712 713 714 715 716 717 718 719 720 > >| 第 716/6274 页